BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35995297)

  • 1. Spheroplexes: Hybrid PLGA-cationic lipid nanoparticles, for in vitro and oral delivery of siRNA.
    Arruda DC; Lachagès AM; Demory H; Escriou G; Lai-Kuen R; Dugas PY; Hoffmann C; Bessoles S; Sarrabayrouse G; Malachias A; Finet S; Gastelois PL; de Almeida Macedo WA; da Silva Cunha A; Bigey P; Escriou V
    J Control Release; 2022 Oct; 350():228-243. PubMed ID: 35995297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering of Solid Dosage Forms of siRNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles Using a Quality-by-Design Approach.
    Lokras A; Foged C; Thakur A
    Methods Mol Biol; 2021; 2282():137-157. PubMed ID: 33928574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation.
    Kubota K; Onishi K; Sawaki K; Li T; Mitsuoka K; Sato T; Takeoka S
    Int J Nanomedicine; 2017; 12():5121-5133. PubMed ID: 28790820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model.
    Jansen MAA; Klausen LH; Thanki K; Lyngsø J; Skov Pedersen J; Franzyk H; Nielsen HM; van Eden W; Dong M; Broere F; Foged C; Zeng X
    Eur J Pharm Biopharm; 2019 Sep; 142():38-48. PubMed ID: 31199978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach.
    Thanki K; Zeng X; Justesen S; Tejlmann S; Falkenberg E; Van Driessche E; Mørck Nielsen H; Franzyk H; Foged C
    Eur J Pharm Biopharm; 2017 Nov; 120():22-33. PubMed ID: 28756280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration.
    Thanki K; van Eetvelde D; Geyer A; Fraire J; Hendrix R; Van Eygen H; Putteman E; Sami H; de Souza Carvalho-Wodarz C; Franzyk H; Nielsen HM; Braeckmans K; Lehr CM; Ogris M; Foged C
    J Control Release; 2019 Sep; 310():82-93. PubMed ID: 31398360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
    Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J
    ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoplexes Strengthened by Anionic Polymers: Easy Preparation of Highly Effective siRNA Vectors Based on Cationic Lipids and Anionic Polymers.
    Arruda DC; Schlegel A; Bigey P; Escriou V
    Methods Mol Biol; 2016; 1445():137-48. PubMed ID: 27436316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(lactide-
    Wu L; Wu LP; Wu J; Sun J; He Z; Rodríguez-Rodríguez C; Saatchi K; Dailey LA; Häfeli UO; Cun D; Yang M
    ACS Appl Mater Interfaces; 2021 Jan; 13(3):3722-3737. PubMed ID: 33439616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
    Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
    J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anionic polymers for decreased toxicity and enhanced in vivo delivery of siRNA complexed with cationic liposomes.
    Schlegel A; Largeau C; Bigey P; Bessodes M; Lebozec K; Scherman D; Escriou V
    J Control Release; 2011 Jun; 152(3):393-401. PubMed ID: 21497175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cationic lipid nanoparticle production by microfluidization for siRNA delivery.
    Liu X; Bahloul B; Lai Kuen R; Andrieux K; Roques C; Scherman D
    Int J Pharm; 2021 Aug; 605():120772. PubMed ID: 34098051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery.
    Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q
    Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifying internal organization and surface morphology of siRNA lipoplexes by sodium alginate addition for efficient siRNA delivery.
    Arruda DC; Gonzalez IJ; Finet S; Cordova L; Trichet V; Andrade GF; Hoffmann C; Bigey P; de Almeida Macedo WA; Da Silva Cunha A; Malachias de Souza A; Escriou V
    J Colloid Interface Sci; 2019 Mar; 540():342-353. PubMed ID: 30660791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of PLGA-Lipid Hybrid Nanoparticles for siRNA Delivery Using the Emulsion Method PLGA-PEG-Lipid Nanoparticles for siRNA Delivery.
    Wang L; Griffel B; Xu X
    Methods Mol Biol; 2017; 1632():231-240. PubMed ID: 28730443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
    Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
    J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
    Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
    J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cationic lipids in cationic liposomes and disaccharides in the freeze-drying of siRNA lipoplexes on gene silencing in cells by reverse transfection.
    Hattori Y; Hu S; Onishi H
    J Liposome Res; 2020 Sep; 30(3):235-245. PubMed ID: 31185779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic profiling of the siRNA delivery dynamics of lipid-polymer hybrid nanoparticles.
    Colombo S; Cun D; Remaut K; Bunker M; Zhang J; Martin-Bertelsen B; Yaghmur A; Braeckmans K; Nielsen HM; Foged C
    J Control Release; 2015 Mar; 201():22-31. PubMed ID: 25540904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.